U.S. missile stockpiles dwindle. And, FDA weighs approval of flu shots with mRNA tech
The U.S. military is facing a depletion of long-range precision missiles due to ongoing conflicts, raising concerns about future readiness and the ability to support allies like Ukraine. Separately, the FDA is evaluating the use of mRNA technology for upcoming flu vaccines.
Why it matters
Supply chain constraints in defense manufacturing could impact U.S. geopolitical strategy, while mRNA advancements represent a significant shift in public health technology.
Good morning. You're reading the Up First newsletter. Subscribe here to get it delivered to your inbox, and listen to the Up First podcast for all the news you need to start your day.
The U.S. Army has used most of its long-range attack missiles in the war with Iran , NPR has confirmed. A U.S. official, speaking on the condition of anonymity because they were not authorized to speak publicly, said that precision missiles like PrSMs and ATCAMs are nearly depleted. These offensive weapons can strike from hundreds of miles away, providing crucial protection for U.S. servicemembers by reducing the need for American pilots to approach enemy targets closely.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in